All Product News

Integra LifeSciences Selected for Healogics iSupply℠ Program

Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced it has been selected as a primary provider for cellular-based tissue products within Healogics® Inc. new iSupply program. This program is exclusively available to Healogics’ hospital partners and is focused on ensuring hospitals and patients receive the best value from wound care products commonly used in Wound Care Centers® and other sites of care.

AlloSource and Integra LifeSciences Announce Anchor Gifts to Phoenix Society for Burn Survivors' Never Alone Campaign

AlloSource, one of the nation's largest providers of cellular and tissue allografts, and Integra LifeSciences, a leading global medical technology company, today announced anchor gift donations to the Phoenix Society for Burn Survivors' Never Alone Campaign. The campaign is dedicated to raising money for strategic initiatives that will enable the Phoenix Society to provide a community of support, as well as resources and tools, for burn survivors and their families.

Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Añasco, Puerto Rico

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its manufacturing facility in Añasco, Puerto Rico sustained relatively minor damage from the impact of Hurricane Maria. A team is on-site to oversee repairs.

Integra Launches Next Generation Ultrasonic Tissue Ablation System

CUSA® Clarity system achieves greater than 50% increase in fibrous tissue removal rate*

Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today

Integra LifeSciences Announces that Omnigraft™ Dermal Regeneration Matrix was Recognized as a Top Ten Innovation by Podiatry Today